|
|
Emerging Therapeutic Strategies for Metabolic Disorders 2010 will attract industry leaders and academic experts from well-known organizations and prominent universities throughout Europe to discuss about topics related to the development of treatments for metabolic disorders.The conference will present the pharmaceutical industry with new treatments for diabetes, cardiovascular disease, obesity and other associated conditions. The event will provide a wonderful opportunity for face to face networking and interaction with specialists and experts.
The conference will cover a wide range of topics such as:
- The endothelium as a target for pharmacological interventions
- New insulin sensitizer drugs
- Anti-CD3 monoclonal antibodies
- DPP-4 inhibitors and GLP-1 receptor agonists
- Compounds that alter metabolic activity
- Small molecule therapeutics for lysosomal disorders
- Treatment of cardiovascular risk in obese and diabetic patients
Visitor Profile
The targeted visitors at Emerging Therapeutic Strategies for Metabolic Disorders 2010 would include drug development scientists and product managers associated with:
- Biotherapeutics
- Pont of Care
- Nutrition
- Therapeutic antibodies
- Endocrinology
- Metabolic disorders
- Metabolic diseases
- Cardiometabolic diseases
- Cardiovascular disease
- Obesity
- Diabetes
Organizer
SMi
